Mediastinitis
16
0
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
90.0%
+3.5% vs benchmark
13%
2 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients
Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections.
The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After Sternotomy
Use of Platelet-Rich Plasma to Reduce Sternal Wound Complications After CABG With Median Sternotomy
Combined Air-plasma Flow and Nitric Oxide Therapy in Cardiac Surgery
Infectious Mediastinitis Among the Strasbourg Universitary Hospital
Prognostic Factors for Descending Necrotizing Mediastinitis Development in Deep Space Neck Infections
Post-Surgical Mediastinitis Within the CHU Brugmann Hospital
Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients
Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain
Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)
Physiotherapy Exercises in Patients With Sternal Instability After Cardiovascular Surgery
Delayed Primary Versus Late Secondary Wound Closure in Sternum Infections
Rapid Sternal Closure System (TALON)
Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks